Enanta Pharmaceuticals (ENTA) Q1 2026 Earnings

Feb 9Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.15
-0.9
-0.66
-0.42

Details

Expected EPS
-0.767654
Actual EPS
-0.42
Surprise EPS
0.35
Surprise Percent
+45.29%

Description

⁨Enanta Pharmaceuticals⁩ (⁦ENTA⁩) has reported earnings of ⁦-0.42⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts